Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 4, 2004, Pages 395-399

  Hopkinson, Nicholas S ^a   Nickol, Annabel H ^b   Payne, John ^b   Hawe, Emma ^b   Man, William D C ^b   Moxham, John ^b   Montgomery, Hugh ^b   Polkey, Michael I ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Gene polymorphism; Respiratory muscle; Skeletal muscle

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; PREDNISONE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; BODY MASS; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMORAL NERVE; FORCED EXPIRATORY VOLUME; GENE DELETION; GENE INSERTION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCLE TWITCH; NERVE STIMULATION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE;

COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PEPTIDYL-DIPEPTIDASE A; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES;

EID: 4544347006     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200304-578OC     Document Type: Article

References (48)

1. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033-1047.
2. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:859-867.
3. Decramer M, Gosselink R, Troosters T, Verscheueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997;10:417-423.
4. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-940.
5. Dragovic T, Minshall R, Jackman HL, Wang LX, Erdos EG. Kininase II-type enzymes: their putative role in muscle energy metabolism. Diabetes 1996;45:S34-S37.
6. Cobb CS, Frankling SC, Rankin JC, Brown JA. Angiotensin converting enzyme-like activity in tissues from the river lamprey or lampern, Lampetra fluviatilis, acclimated to freshwater and seawater. Gen Comp Endocrinol 2002;127:8-15.
7. Reneland R, Lithell H. Angiotensin-converting enzyme in human skeletal muscle: a simple in vitro assay of activity in needle biopsy specimens. Scand J Clin Lab Invest 1994;54:105-111.
8. Reneland R, Haenni A, Andersson PE, Andren B, Lithell H. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men. Blood Press 1999;8:16-22.
9. Schaufelberger M, Drexler H, Schieffer E, Swedberg K. Angiotensin-converting enzyme gene expression in skeletal muscle in patients with chronic heart failure. J Card Fail 1998;4:185-191.
10. Vaghy PL, Russell JS, Lantry LE, Stephens RE, Ward PE. Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblasts. Peptides 1995;16:1367-1373.
11. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
12. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 1995;92:1387-1388.
13. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.
14. Brown NJ, Blais C Jr, Gandhi SK, Adam A. ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 1998;32:373-377.
15. Brull DJ, Sanders J, Rumley A, Lowe GD, Humphries SE, Montgomery HE. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart 2002;87:252-255.
16. Jones A, Woods DR. Skeletal muscle RAS and exercise performance. Int J Biochem Cell Biol 2003;35:855-866.
17. Henriksen EJ, Jacob S. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J Cell Physiol 2003;196:171-179.
18. Amaral SL, Papanek PE, Greene AS. Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. Am J Physiol Heart Circ Physiol 2001;281:H1163-H1169.
19. Gordon SE, Davis BS, Carlson CJ, Booth FW. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab 2001;280:E150-E159.
20. Rattigan S, Dora KA, Tong AC, Clark MG. Perfused skeletal muscle contraction and metabolism improved by angiotensin II-mediated vasoconstriction. Am J Physiol 1996;271:E96-103.
21. Folland J, Leach B, Little T, Hawker K, Myerson S, Montgomery H, Jones D. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 2000;85:575-579.
22. Hopkinson N, Nickol A, Payne J, Hawe E, Man WD-C, Moxham J, Montgomery HE, Polkey MI. ACE gene deletion protects against quadriceps weakness in COPD. Thorax 2003;58:79.
23. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: workshop summary of NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD). Am J Respir Crit Care Med 2001;163:1256-1276.
24. Hopkinson NS, Dayer MJ, Ross E, Hart N, Nickol AH, Moxham J, Polkey MI. Acute effects of corticosteroid treatment on quadriceps strength in COPD. Eur Respir J 2004;24:1-6.
25. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows: report of Working Party Standardization of Lung Function Tests, European Community for Steel and Coal and official statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
26. Steiner MC, Barton RL, Singh SJ, Morgan MD. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002;19:626-631.
27. Edwards RHT, Young A, Hosking GP, Jones DA. Human skeletal muscle function: description of tests and normal values. Clin Sci 1977;52:283-290.
28. Polkey MI, Kyroussis D, Hamnegard CH, Mills GH, Green M, Moxham J. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 1996;19:549-555.
29. Uldry C, Janssens JP, de Muralt B, Fitting JW. Sniff nasal inspiratory pressure in patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:1292-1296.
30. O'Dell SD, Humphries SE, Day IN. Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J 1995;73:368-371.
31. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost 1996;75:767-771.
32. Narici MV, Roi GS, Landoni L, Minetti AE, Cerretelli P. Changes in force, cross-sectional area and neural activation during strength training and detraining of the human quadriceps. Eur J Appl Physiol Occup Physiol 1989;59:310-319.
33. Wali FA. Effect of angiotensin II on mechanical and electrical responses of frog, chick and rat skeletal muscle. Arch Int Pharmacodyn Ther 1986;282:314-327.
34. Jonsson JR, Smid SD, Frewin DB, Head RJ. Angiotensin II-mediated facilitation of sympathetic neurotransmission in the spontaneously hypertensive rat is not associated with neuronal uptake of the peptide. J Cardiovasc Pharmacol 1993;22:750-753.
35. Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M, Saku K. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 2003;63:139-144.
36. O2 with small muscle mass exercise. Am J Respir Crit Care Med 2004;169:89-96.
37. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, Hemingway H, Statters D, Jubb M, Girvain M, Varnava A, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997;96:741-747.
38. Engelen MP, Schols AM, Lamers RJ, Wouters EF. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 1999;18:275-280.
39. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-634.
40. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-980.
41. Serres I, Gautier V, Varray A, Prefaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998;113:900-905.
42. Bourjeily-Habr G, Rochester CL, Palermo F, Snyder P, Mohsenin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax 2002;57:1045-1049.
43. Bellemare F, Grassino A. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 1983;55:8-15.
44. Polkey MI, Kyroussis D, Hamnegard CH, Mills GH, Green M, Moxham J. Diaphragm strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:1310-1317.
45. Levine S, Gregory C, Nguyen T, Shrager J, Kaiser L, Rubinstein N, Dudlev G. Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol 2002;92:1205-1213.
46. van Suylen RJ, Wouters EF, Pennings HJ, Cheriex EC, van Pol PE, Ambergen AW, Vermelis AM, Daemen MJ. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1791-1795.
47. Kanazawa H, Otsuka T, Hirata K, Yoshikawa J. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 2002;121:697-701.
48. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Lonescu AA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-368.